GR3004513T3 - - Google Patents

Info

Publication number
GR3004513T3
GR3004513T3 GR920400746T GR920400746T GR3004513T3 GR 3004513 T3 GR3004513 T3 GR 3004513T3 GR 920400746 T GR920400746 T GR 920400746T GR 920400746 T GR920400746 T GR 920400746T GR 3004513 T3 GR3004513 T3 GR 3004513T3
Authority
GR
Greece
Application number
GR920400746T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004513T3 publication Critical patent/GR3004513T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GR920400746T 1986-01-31 1992-05-07 GR3004513T3 (US07498051-20090303-C00003.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61020361A JPH0696521B2 (ja) 1986-01-31 1986-01-31 眼局所投与用眼圧降下剤

Publications (1)

Publication Number Publication Date
GR3004513T3 true GR3004513T3 (US07498051-20090303-C00003.png) 1993-04-28

Family

ID=12024951

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400746T GR3004513T3 (US07498051-20090303-C00003.png) 1986-01-31 1992-05-07

Country Status (9)

Country Link
US (1) US4826879A (US07498051-20090303-C00003.png)
EP (1) EP0235544B1 (US07498051-20090303-C00003.png)
JP (1) JPH0696521B2 (US07498051-20090303-C00003.png)
AU (1) AU591228B2 (US07498051-20090303-C00003.png)
CA (1) CA1282704C (US07498051-20090303-C00003.png)
DE (1) DE3777858D1 (US07498051-20090303-C00003.png)
ES (1) ES2032390T3 (US07498051-20090303-C00003.png)
GR (1) GR3004513T3 (US07498051-20090303-C00003.png)
HU (1) HU199285B (US07498051-20090303-C00003.png)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863948A (en) * 1985-06-14 1999-01-26 Massachusetts Eye And Ear Infirmary Increasing aqueous humor outflow
US5306731A (en) * 1985-06-14 1994-04-26 Massachusetts Eye And Ear Infirmary Method and products for treating the eye
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5314916A (en) * 1993-04-19 1994-05-24 Alcon Laboratories, Inc. B2 adrenegic agonists and use thereof in the treatment of glaucoma
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
US6162393A (en) * 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US8557868B2 (en) * 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
US20070098813A1 (en) * 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions with a peroxide source and a preservative
US9492582B2 (en) * 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
JP4084997B2 (ja) 2000-11-08 2008-04-30 エフエックスエス・ベンチャーズ・エルエルシー 防腐剤増強剤として単純糖類を含有する改良眼科用およびコンタクトレンズ用溶液
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
US20060127496A1 (en) * 2000-11-08 2006-06-15 Bioconcept Laboratories L-histidine in ophthalmic solutions
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
US20060148665A1 (en) * 2000-11-08 2006-07-06 Bioconcept Laboratories Ophthalmic and contact lens solutions containing forms of vitamin b
WO2004091438A2 (en) * 2003-04-15 2004-10-28 Fxs Ventures, Llc Improved ophthalmic and contact lens solutions containing peptides as representative enhancers
BRPI0613034A8 (pt) 2005-07-14 2018-01-02 Lipothera Inc formulação injetável para acúmulo de tecido adiposo, formulação injetável e método para o tratamento de acúmulo de gordura, e, método para reduzir o tecido adiposo.
US20100119609A1 (en) * 2006-10-17 2010-05-13 John Daniel Dobak Methods, compositions, and formulations for the treatment of thyroid eye disease
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
EA028679B1 (ru) * 2010-01-15 2017-12-29 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" Составы в виде лиофилизированного кека
EP2646012A4 (en) 2010-11-24 2014-12-10 Neothetics Inc MONOTHERAPEUTIC FORMULATIONS OF SELECTIVE, LIPOPHILIC AND PROLONGED BETA AGONISTS AND METHODS OF COSMETIC TREATMENT OF SILHOUETTE ADPOSITY AND REINFORCEMENT
CN102584801B (zh) * 2011-01-06 2015-02-18 中国科学院上海有机化学研究所 Hiv逆转录酶抑制剂依法韦伦类化合物的一锅法不对称合成工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826332B2 (ja) * 1974-04-25 1983-06-02 武田薬品工業株式会社 テトラロ−ルカゴウブツ ノ セイゾウホウ
JPS5833219B2 (ja) * 1974-06-12 1983-07-18 武田薬品工業株式会社 テトラロ−ルカゴウブツノ セイゾウホウ
DK254975A (da) * 1974-06-12 1975-12-13 Takeda Chemical Industries Ltd Fremgangsmade til fremstilling af aminotetralolforbindelser
JPS5283826A (en) * 1976-01-01 1977-07-13 Takeda Chem Ind Ltd Tetralol compound
US4402976A (en) * 1981-04-24 1983-09-06 E. R. Squibb & Sons, Inc. Method for treating glaucoma with systemic nadolol compositions
JPS5970653A (ja) * 1982-10-15 1984-04-21 Takeda Chem Ind Ltd 眼圧低下剤
IT1163107B (it) * 1983-02-15 1987-04-08 Simes Composizioni farmaceutiche e loro uso nel trattamento del glaucoma

Also Published As

Publication number Publication date
EP0235544A3 (en) 1989-11-29
EP0235544B1 (en) 1992-04-01
US4826879A (en) 1989-05-02
AU6813987A (en) 1987-08-06
DE3777858D1 (de) 1992-05-07
EP0235544A2 (en) 1987-09-09
JPH0696521B2 (ja) 1994-11-30
AU591228B2 (en) 1989-11-30
HUT46210A (en) 1988-10-28
CA1282704C (en) 1991-04-09
HU199285B (en) 1990-02-28
ES2032390T3 (es) 1996-07-16
JPS62178514A (ja) 1987-08-05

Similar Documents

Publication Publication Date Title
IN165820B (US07498051-20090303-C00003.png)
IN168444B (US07498051-20090303-C00003.png)
DE3790206T1 (US07498051-20090303-C00003.png)
FR2607647B1 (US07498051-20090303-C00003.png)
DK8603255A (US07498051-20090303-C00003.png)
FR2612769B1 (US07498051-20090303-C00003.png)
DE3790018T1 (US07498051-20090303-C00003.png)
DE3690814T1 (US07498051-20090303-C00003.png)
AU7354491A (US07498051-20090303-C00003.png)
AU6562586A (US07498051-20090303-C00003.png)
AU7131791A (US07498051-20090303-C00003.png)
AU5130285A (US07498051-20090303-C00003.png)
AU5480786A (US07498051-20090303-C00003.png)
AU5745586A (US07498051-20090303-C00003.png)
AU5130385A (US07498051-20090303-C00003.png)
AU4946385A (US07498051-20090303-C00003.png)
IN168110B (US07498051-20090303-C00003.png)
AU4910985A (US07498051-20090303-C00003.png)
AU5173485A (US07498051-20090303-C00003.png)
AU5227086A (US07498051-20090303-C00003.png)
AU6211586A (US07498051-20090303-C00003.png)
AU6161186A (US07498051-20090303-C00003.png)
AU5329886A (US07498051-20090303-C00003.png)
AU5344086A (US07498051-20090303-C00003.png)
AU5348186A (US07498051-20090303-C00003.png)